| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C11H11F3N2O3
|
|---|
| Exact mass |
276.0722
|
|---|
| Mol weight |
276.21
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Pathway |
|
|---|
| Network |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BB Anti-androgens
L02BB01 Flutamide
D00586 Flutamide (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Antiandrogens
Flutamide
D00586 Flutamide (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D00586 Flutamide (JP18/USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01591 Androgen receptor antagonist
DG01624 Flutamide-type antiandrogen
D00586 Flutamide
Drug classes [BR:br08332]
Antineoplastic
DG01591 Androgen receptor antagonist
D00586 Flutamide
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D00586 Flutamide (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00586 Flutamide
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C8x C 37.4824 -21.0933
2 C8y C 38.6779 -20.4604
3 C8x C 36.2166 -20.4604
4 C8y C 38.6779 -19.0539
5 N2b N 39.8733 -21.0933 #+
6 C8y C 36.2166 -19.0539
7 C8x C 37.4824 -18.3507
8 O3a O 39.8733 -22.4997
9 O3a O 41.1391 -20.3901 #-
10 N1b N 35.0211 -18.3507
11 C5a C 33.8257 -19.0539
12 C1c C 32.6302 -18.3507
13 O5a O 33.8257 -20.3901
14 C1a C 31.3644 -19.0539
15 C1a C 32.6302 -16.9443
16 C1d C 39.8987 -18.3557
17 X F 41.1167 -17.6524
18 X F 39.1955 -17.1377
19 X F 40.6020 -19.5737
BOND 19
1 1 2 2
2 1 3 1
3 2 4 1
4 2 5 1
5 3 6 2
6 4 7 2
7 5 8 2
8 5 9 1
9 6 10 1
10 10 11 1
11 11 12 1
12 11 13 2
13 12 14 1
14 12 15 1
15 6 7 1
16 4 16 1
17 16 17 1
18 16 18 1
19 16 19 1
|
|---|
